950 Stock Overview
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Lee's Pharmaceutical Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$1.21 |
52 Week High | HK$1.75 |
52 Week Low | HK$1.00 |
Beta | 0.86 |
11 Month Change | -2.42% |
3 Month Change | -0.82% |
1 Year Change | 0% |
33 Year Change | -70.63% |
5 Year Change | -74.15% |
Change since IPO | 132.69% |
Recent News & Updates
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem
Sep 04There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price
Aug 07Recent updates
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem
Sep 04There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price
Aug 07Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01
May 21Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking
Dec 20Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Apr 02Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Aug 29Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?
Apr 05Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?
Mar 17Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?
Feb 22What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 29What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?
Jan 12Have Insiders Sold Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Recently?
Dec 22Shareholder Returns
950 | HK Pharmaceuticals | HK Market | |
---|---|---|---|
7D | -2.4% | -1.1% | -3.5% |
1Y | 0% | 10.6% | -1.0% |
Return vs Industry: 950 underperformed the Hong Kong Pharmaceuticals industry which returned 10.6% over the past year.
Return vs Market: 950 matched the Hong Kong Market which returned -1% over the past year.
Price Volatility
950 volatility | |
---|---|
950 Average Weekly Movement | 5.1% |
Pharmaceuticals Industry Average Movement | 5.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in HK Market | 13.1% |
10% least volatile stocks in HK Market | 3.3% |
Stable Share Price: 950 has not had significant price volatility in the past 3 months.
Volatility Over Time: 950's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 1,057 | n/a | www.leespharm.com |
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. It focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates through Proprietary and Generic Products; and Licensed-In Products segments.
Lee's Pharmaceutical Holdings Limited Fundamentals Summary
950 fundamental statistics | |
---|---|
Market cap | HK$712.49m |
Earnings (TTM) | HK$63.06m |
Revenue (TTM) | HK$1.20b |
11.3x
P/E Ratio0.6x
P/S RatioIs 950 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
950 income statement (TTM) | |
---|---|
Revenue | HK$1.20b |
Cost of Revenue | HK$581.63m |
Gross Profit | HK$617.44m |
Other Expenses | HK$554.38m |
Earnings | HK$63.06m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.11 |
Gross Margin | 51.49% |
Net Profit Margin | 5.26% |
Debt/Equity Ratio | 14.2% |
How did 950 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield28%
Payout RatioDoes 950 pay a reliable dividends?
See 950 dividend history and benchmarksLee's Pharmaceutical Holdings dividend dates | |
---|---|
Ex Dividend Date | Sep 12 2024 |
Dividend Pay Date | Oct 03 2024 |
Days until Ex dividend | 4 days |
Days until Dividend pay date | 25 days |
Does 950 pay a reliable dividends?
See 950 dividend history and benchmarks